IL104289A0 - Process and uses for 4,5-dihydrogel-danamycin and its hydroquinone - Google Patents
Process and uses for 4,5-dihydrogel-danamycin and its hydroquinoneInfo
- Publication number
- IL104289A0 IL104289A0 IL104289A IL10428992A IL104289A0 IL 104289 A0 IL104289 A0 IL 104289A0 IL 104289 A IL104289 A IL 104289A IL 10428992 A IL10428992 A IL 10428992A IL 104289 A0 IL104289 A0 IL 104289A0
- Authority
- IL
- Israel
- Prior art keywords
- dihydrogel
- danamycin
- hydroquinone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81723592A | 1992-01-06 | 1992-01-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL104289A0 true IL104289A0 (en) | 1993-05-13 |
Family
ID=25222638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL104289A IL104289A0 (en) | 1992-01-06 | 1992-12-31 | Process and uses for 4,5-dihydrogel-danamycin and its hydroquinone |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPH06510913A (en) |
| KR (1) | KR940703923A (en) |
| CN (1) | CN1074937A (en) |
| AU (1) | AU3225693A (en) |
| BR (1) | BR9207024A (en) |
| CA (1) | CA2127457A1 (en) |
| CZ (1) | CZ390592A3 (en) |
| FI (1) | FI943207L (en) |
| HU (1) | HU9401936D0 (en) |
| IL (1) | IL104289A0 (en) |
| MX (1) | MX9300011A (en) |
| NO (1) | NO942532D0 (en) |
| PT (1) | PT101169A (en) |
| WO (1) | WO1993014215A1 (en) |
| ZA (1) | ZA9333B (en) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2166320A1 (en) * | 1993-06-29 | 1995-01-12 | Randall James Gallaschun | Ansamycin derivatives as antioncogene and anticancer agents |
| US5932566A (en) * | 1994-06-16 | 1999-08-03 | Pfizer Inc. | Ansamycin derivatives as antioncogene and anticancer agents |
| US6852496B1 (en) | 1997-08-12 | 2005-02-08 | Oregon Health And Science University | Methods of screening for agents that promote nerve cell growth |
| US6872715B2 (en) * | 2001-08-06 | 2005-03-29 | Kosan Biosciences, Inc. | Benzoquinone ansamycins |
| EP1923061A1 (en) | 2001-09-24 | 2008-05-21 | Conforma Therapeutic Corporation | Process for preparing 17-Allyl amino geldanamycin (17-AAG) and other ansamycins |
| ATE387198T1 (en) | 2001-09-24 | 2008-03-15 | Conforma Therapeutic Corp | METHOD FOR PRODUCING 17-ALLYL-AMINO-MONEYANAMYCIN (17-AAG) AND OTHER ANSAMYCINS |
| CA2474508A1 (en) | 2002-02-08 | 2003-08-14 | Conforma Therapeutics Corporation | Ansamycins having improved pharmacological and biological properties |
| TW200303363A (en) * | 2002-02-25 | 2003-09-01 | Upjohn Co | Process to prepare and isolate geldanamycin |
| WO2005009345A2 (en) | 2003-06-13 | 2005-02-03 | Kosan Biosciences, Inc. | 2-desmethyl ansamycin compounds |
| CA2545457A1 (en) | 2003-11-12 | 2005-06-23 | Kosan Biosciences, Inc. | 11-o-methylgeldanamycin compounds |
| US6855705B1 (en) | 2003-11-12 | 2005-02-15 | Kosan Biosciences, Inc. | 11-O-methylgeldanamycin compounds |
| US6875863B1 (en) | 2003-11-12 | 2005-04-05 | Kosan Biosciences, Inc. | 11-O-methylgeldanamycin compounds |
| US6887993B1 (en) | 2003-11-12 | 2005-05-03 | Kosan Biosciences, Inc. | 11-O-methylgeldanamycin compounds |
| US20050148496A1 (en) * | 2003-11-26 | 2005-07-07 | Entelos, Inc. | Treatment of rheumatoid arthritis with hypoxia inducible factor-1alpha antagonists |
| CN1898212B (en) * | 2003-12-23 | 2012-06-13 | 无限发现公司 | Benzoquinone-containing ansamycin analogs for the treatment of cancer |
| US20060019941A1 (en) * | 2003-12-23 | 2006-01-26 | Infinity Pharmaceuticals, Inc. | Analogs of benzoquinone-containing ansamycins and methods of use thereof |
| CA2547343C (en) * | 2003-12-23 | 2013-05-14 | Infinity Pharmaceuticals, Inc. | Analogs of benzoquinone-containing ansamycins for the treatment of cancer |
| JP2008534609A (en) | 2005-03-30 | 2008-08-28 | コンフォーマ・セラピューティクス・コーポレイション | Alkynylpyrrolopyrimidines and related analogs as HSP90 inhibitors |
| US8492370B2 (en) * | 2006-11-09 | 2013-07-23 | Bristol-Myers Squibb Company | Compounds and methods for their production |
| PE20081506A1 (en) | 2006-12-12 | 2008-12-09 | Infinity Discovery Inc | ANSAMYCIN FORMULATIONS |
| CN100500668C (en) * | 2006-12-19 | 2009-06-17 | 中国人民解放军军事医学科学院毒物药物研究所 | Geldanamycin derivative and its preparing method and use for preparing medicine |
| US7855192B2 (en) | 2007-01-26 | 2010-12-21 | Kosan Biosciences, Inc. | Macrolactams by engineered biosynthesis |
| WO2009130706A1 (en) * | 2008-04-21 | 2009-10-29 | Biocon Limited | A process for isolation and purification of geldanamycin |
| CA2739928A1 (en) | 2008-10-15 | 2010-04-22 | Infinity Pharmaceuticals, Inc. | Ansamycin hydroquinone compositions |
| CN102030764B (en) * | 2010-11-12 | 2012-07-04 | 中国医学科学院医药生物技术研究所 | 4,5-dihydro-thiazinogeldanamycin and preparation method thereof |
| CN103305563B (en) * | 2013-06-14 | 2014-12-03 | 湖南农业大学 | Method for extracting alisamycin from streptomyces |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3595955A (en) * | 1969-03-26 | 1971-07-27 | Upjohn Co | Geldanamycin and process for producing same |
-
1992
- 1992-12-03 WO PCT/US1992/010189 patent/WO1993014215A1/en not_active Ceased
- 1992-12-03 CA CA002127457A patent/CA2127457A1/en not_active Abandoned
- 1992-12-03 KR KR1019940702334A patent/KR940703923A/en not_active Ceased
- 1992-12-03 HU HU9401936A patent/HU9401936D0/en unknown
- 1992-12-03 FI FI943207A patent/FI943207L/en unknown
- 1992-12-03 BR BR9207024A patent/BR9207024A/en not_active Application Discontinuation
- 1992-12-03 AU AU32256/93A patent/AU3225693A/en not_active Abandoned
- 1992-12-03 JP JP5512423A patent/JPH06510913A/en active Pending
- 1992-12-15 CN CN92113885A patent/CN1074937A/en active Pending
- 1992-12-28 CZ CS923905A patent/CZ390592A3/en unknown
- 1992-12-31 IL IL104289A patent/IL104289A0/en unknown
-
1993
- 1993-01-04 PT PT101169A patent/PT101169A/en not_active Application Discontinuation
- 1993-01-05 ZA ZA9333A patent/ZA9333B/en unknown
- 1993-01-05 MX MX9300011A patent/MX9300011A/en unknown
-
1994
- 1994-07-05 NO NO942532A patent/NO942532D0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9207024A (en) | 1995-12-05 |
| CN1074937A (en) | 1993-08-04 |
| PT101169A (en) | 1994-03-31 |
| MX9300011A (en) | 1993-12-01 |
| FI943207A7 (en) | 1994-07-05 |
| AU3225693A (en) | 1993-08-03 |
| FI943207A0 (en) | 1994-07-05 |
| NO942532L (en) | 1994-07-05 |
| HU9401936D0 (en) | 1994-09-28 |
| NO942532D0 (en) | 1994-07-05 |
| ZA9333B (en) | 1994-07-05 |
| JPH06510913A (en) | 1994-12-08 |
| CZ390592A3 (en) | 1993-08-11 |
| KR940703923A (en) | 1994-12-12 |
| CA2127457A1 (en) | 1993-07-22 |
| FI943207L (en) | 1994-07-05 |
| WO1993014215A1 (en) | 1993-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA9333B (en) | Process and uses for 4,5-dihydrogeldanamycin and its hydroquinone | |
| ZA938826B (en) | Process | |
| GB9218346D0 (en) | Process | |
| GB9203375D0 (en) | Process | |
| KR970000398B1 (en) | Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethan and pentafluorethane | |
| SG73396A1 (en) | Hydrotrating process | |
| GB9202375D0 (en) | Process | |
| IL105168A0 (en) | Heteroannulation process | |
| GB9220068D0 (en) | Process | |
| IL104303A0 (en) | Process | |
| ZA939517B (en) | Process | |
| GB9215438D0 (en) | Process | |
| GB9201496D0 (en) | Process | |
| AP9300473A0 (en) | Process | |
| GB9225202D0 (en) | Process | |
| GB9220526D0 (en) | Process | |
| GB9301562D0 (en) | Process | |
| GB9225373D0 (en) | Novel compounds and process | |
| GB9216664D0 (en) | Novel compounds and process | |
| GB9216662D0 (en) | Novel compounds and process | |
| GB9207510D0 (en) | Process | |
| GB9204277D0 (en) | Process | |
| GB9201515D0 (en) | Process | |
| GB9201121D0 (en) | Process | |
| GB9217249D0 (en) | Process |